跳至主要内容
临床试验/JPRN-UMIN000011650
JPRN-UMIN000011650已完成未知

ow dose atrial natriuretic peptide provides effective renal protection from acute kidney injury after aortic arch surgery: a randomised controlled trial - Kawasaki ANP trial

Kawasaki Saiwai Hospital0 个研究点目标入组 43 人开始时间: 2013年9月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)an additional procedure was planned or undertaken 2)the arterial or venous cannulation sites were modified 3)the patient required an ANP infusion to treat perioperative acute heart failure 4)the patient age under 20 years 5)the patient had a history of adverse reaction to atrial natriuretic peptide 6)mean arterial blood pressure could not be maintained above 50 mmHg despite the administration of a positive inotrope or vasopressor after weaning from cardiopulmonary bypass.

研究者

发起方
Kawasaki Saiwai Hospital

相似试验